share_log

IRIDEX | 8-K: Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022 Achieves Record Quarterly Glaucoma Probe sales and 6% Full Year Revenue Growth

SEC ·  Jan 11, 2023 05:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more